These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 23237765)
1. Use of pregabalin for nonconvulsive seizures and nonconvulsive status epilepticus. Swisher CB; Doreswamy M; Husain AM Seizure; 2013 Mar; 22(2):116-8. PubMed ID: 23237765 [TBL] [Abstract][Full Text] [Related]
3. Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus. Creed JA; Son J; Farjat AE; Swisher CB Seizure; 2018 Jan; 54():45-50. PubMed ID: 29248799 [TBL] [Abstract][Full Text] [Related]
4. Oral pregabalin as an add-on treatment for status epilepticus. Novy J; Rossetti AO Epilepsia; 2010 Oct; 51(10):2207-10. PubMed ID: 20550551 [TBL] [Abstract][Full Text] [Related]
5. Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit. Stephen LJ; Parker P; Kelly K; Wilson EA; Leach V; Brodie MJ Acta Neurol Scand; 2011 Aug; 124(2):142-5. PubMed ID: 21434875 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Nonconvulsive Status Epilepticus and Nonconvulsive Seizures in a Pediatric Intensive Care Unit. Cavusoglu D; Olgac Dundar N; Kamit F; Anil AB; Arican P; Zengin N; Gencpinar P Clin Pediatr (Phila); 2023 Sep; 62(8):879-884. PubMed ID: 36691331 [TBL] [Abstract][Full Text] [Related]
7. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial. Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545 [TBL] [Abstract][Full Text] [Related]
8. Pregabalin in patients with primary brain tumors and seizures: a preliminary observation. Novy J; Stupp R; Rossetti AO Clin Neurol Neurosurg; 2009 Feb; 111(2):171-3. PubMed ID: 18977587 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of nonconvulsive seizures and nonconvulsive status epilepticus in dogs and cats with a history of cluster seizures: A retrospective study. Tästensen C; Gutmann S; Loderstedt S; Flegel T; Demeny H; Baum P J Vet Intern Med; 2024; 38(1):238-246. PubMed ID: 38006289 [TBL] [Abstract][Full Text] [Related]
10. Pregabalin for Recurrent Seizures in Critical Illness: A Promising Adjunctive Therapy, Especially for cyclic Seizures. Busl KM; Fong MWK; Newcomer Z; Patel M; Cohen SA; Jadav R; Smith CN; Mitropanopoulos S; Bruzzone M; Hella M; Eisenschenk S; Robinson CP; Roth WH; Ameli PA; Babi MA; Pizzi MA; Gilmore EJ; Hirsch LJ; Maciel CB Neurocrit Care; 2022 Aug; 37(1):140-148. PubMed ID: 35217998 [TBL] [Abstract][Full Text] [Related]
11. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Arroyo S; Anhut H; Kugler AR; Lee CM; Knapp LE; Garofalo EA; Messmer S; Epilepsia; 2004 Jan; 45(1):20-7. PubMed ID: 14692903 [TBL] [Abstract][Full Text] [Related]
12. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Swisher CB; Doreswamy M; Gingrich KJ; Vredenburgh JJ; Kolls BJ Neurocrit Care; 2012 Feb; 16(1):109-13. PubMed ID: 21882056 [TBL] [Abstract][Full Text] [Related]
13. Incidence of recurrent seizures following hospital discharge in patients with LPDs (PLEDs) and nonconvulsive seizures recorded on continuous EEG in the critical care setting. Punia V; Garcia CG; Hantus S Epilepsy Behav; 2015 Aug; 49():250-4. PubMed ID: 26198216 [TBL] [Abstract][Full Text] [Related]
14. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Carreño M; Maestro I; Molins A; Donaire A; Falip M; Becerra JL; Castillo J Seizure; 2007 Dec; 16(8):709-12. PubMed ID: 17604654 [TBL] [Abstract][Full Text] [Related]
16. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England. Valentin A; Moran N; Hadden R; Oakes A; Elwes R; Delamont R; Mullatti N; Nashef L Seizure; 2009 Jul; 18(6):450-2. PubMed ID: 19213577 [TBL] [Abstract][Full Text] [Related]
17. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644 [TBL] [Abstract][Full Text] [Related]
18. Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients. Brandt C; May TW; Pohlmann-Eden B; Nieder E; Elsner H; Witte-Boelt K; Schuermann I; Ebner A Seizure; 2009 Nov; 18(9):634-8. PubMed ID: 19674920 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication. May TW; Rambeck B; Neb R; Jürgens U Ther Drug Monit; 2007 Dec; 29(6):789-94. PubMed ID: 18043477 [TBL] [Abstract][Full Text] [Related]
20. Nonconvulsive status epilepticus in children: clinical and EEG characteristics. Tay SK; Hirsch LJ; Leary L; Jette N; Wittman J; Akman CI Epilepsia; 2006 Sep; 47(9):1504-9. PubMed ID: 16981867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]